Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance

Journal: Journal of Biological Chemistry

Published: 2020-03-17

DOI: 10.1074/jbc.ra119.011385

Affiliations: 7

Authors: 11

Go to article
Institutions Share
UK Department of Toxicology and Cancer Biology, United States of America (USA) 0.36
Department of Animal Sciences, Purdue University, United States of America (USA) 0.18
KU Department of Biostatistics, United States of America (USA) 0.14
UK Markey Cancer Center, United States of America (USA) 0.14
Department of Biochemistry, Purdue University, United States of America (USA) 0.09
Department of Comparative Pathobiology (CPB), Purdue University, United States of America (USA) 0.05
Center for Cancer Research (PCCR), Purdue University, United States of America (USA) 0.05

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER